StockData
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. (SRPT) bonds

SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3086% below fair value
$14.77−0.36 (-2.38%)

Close on Nov 17, 2026Market cap $1.56BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Sarepta Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Sarepta Therapeutics's 10-Q for the period ended Jun 30, 2026

Coupon by maturity

Each circle is a note, sized by the amount issued. The line is what the US Treasury pays today for the same time to maturity.

IssueCouponMaturesAmount issuedCarrying value
2027 Notes1.25%Sep 15, 2027–$157.81M
Two Thousand And Twenty Seven Senior Convertible Notes
Convertible at $142 a share
1.25%Sep 15, 2027$158.61M–
2030 Notes4.88%Sep 1, 2030–$689.82M
Two Thousand And Thirty Senior Convertible Notes
Convertible at $60 a share
4.88%–$893.39M–
Two Thousand And Twenty Four Senior Convertible Notes
Convertible at $73 a share
1.50%–$570.00M–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Revolving Credit Facility$600.00M

See a number that looks wrong?